Abstract: The present invention provides a peptide having cell membrane penetrating activity, a transmembrane carrier comprising the peptide having cell membrane penetrating activity as an effective component, a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance, a transfection kit comprising the peptide having cell membrane penetrating activity and the target substance, use of the peptide having cell membrane penetrating activity for the manufacture of a transmembrane complex, use of the transmembrane complex for the manufacture of a medicament, and a method for delivering a target substance into cell interior which comprises administrating to a subject with a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance to induce transduction of the transmembrane complex into cell interior.

Abstract: The present invention relates to a magnetic memory cell, which controls the magnetization direction of the free magnetic layer of a Magnetic Tunnel Junction (MTJ) device using a spin torque transfer, and enables the implementation of a magnetic logic circuit, in which memory and logic circuit functions are integrated. The magnetic memory cell includes an MTJ device (10) including a top electrode (11) and a bottom electrode (13), which are provided to allow current to flow therethrough, and a fixed layer (15) and a free layer (17), which are magnetic layers respectively deposited on a top and a bottom of an insulating layer (19), required to insulate the top and bottom electrodes from each other. A current control circuit (50) controls a flow of current flowing between the top and bottom electrodes, and changes a magnetization direction of the free layer according to an input logic level.

Abstract: The present invention relates to an IF address lookup apparatus using a Bloom filter and a multi-hashing architecture that includes a buffering means that outputs a prefix of an inputted address having the number of bits reduced by one bit whenever a control signal is received at the time of outputting the prefix of the inputted address; a hashing hardware that generates a plurality of hashing indexes by hashing the prefix (hereinafter, referred to as “output prefix”) outputted from the buffering means; a Bloom filter that determines whether or not the output prefix is an entry of the hash table by using the plurality of hashing indexes; and a processor that includes the hash table and an overflow table and outputs a prefix that matches the output prefix by searching entries of locations of the hash table indicated by the plurality of hashing indexes and entries stored in the overflow table when a Bloom filter's determination result is positive and outputs the control signal to the buffering means when the ma

Abstract: The present invention relates to a method for inducing the differentiation of CD34+ hematopoietic stem cells into megakaryocytes and platelets, more particularly, a method for inducing the differentiation of CD34+ hematopoietic stem cells into megakaryocytes and platelets comprising the steps of coculturing CD34+ hematopoietic stem cells with stromal cells and adding the compound of Formula 1.

Abstract: Disclosed herein are a method and kit for diagnosing hereditary diseases CMT1A and HNPP, caused by duplication and deletion in the chromosome 17p11.2-p12 region. In accordance with the present invention, there is provided a method for diagnosing an inherited neuropathy, comprising, running the PCR amplification using microsatellites present in a chromosome 17p11.2-p12 region as markers and DNA typing the resulting PCR amplification products to determine the presence of duplication and deletion in the corresponding chromosomal region, wherein Multiplex PCR amplification is carried out using 6 loci of D17S921, D17S9B, D17S9A, D17S918, D17S2230 and D17S4A as markers, and DNA-typing of the resulting PCR amplification products is carried out to determine duplication and deletion in the corresponding chromosomal region. In accordance with the method of the present invention, the diagnosis accuracy of detecting duplication and deletion in the chromosome 17p11.2-p12 region is greater than 99.9%.

Abstract: Method and apparatus for selecting an RS mode in a BWA communication system are provided. In a method for a BS to select an RS mode in a BWA communication system, bidding prices are received from a set of RSs covered by the BS. The winner RS of at least one or more auctions is determined on the basis of the bidding values and the interference information of the RS set. The winner RS is set to operate in an active mode.

Abstract: Disclosed are methods and kits for measuring in situ the activity and amount of an enzyme in a sample using a single measurement system. The method includes the steps of: (a) contacting a sample to a capturing agent having the capacity to bind to the enzyme to be analyzed and immobilized on a solid matrix; (b) measuring the activity of the enzyme captured by the capturing agent; (c) contacting a detection antibody specific to the enzyme captured by the capturing agent; and (d) detecting an antigen-antibody complex formed in the step (c). There is no need for separate measurement system to measure the activity and amount of an enzyme, as well as the above methods and kits permit to measure the precise activity and amount of an enzyme simultaneously because the measurement of enzyme activity and amount is carried out in a single and same measurement system as to the same sample in almost simultaneous manner.

Abstract: The present invention relates to a thermosensitive and biocompatible poly(organophosphazenes) represented by Formula 1, and a preparation method thereof: wherein R is a methyl or ethyl group; R? is selected from the group consisting of COOR, CH2COOR, CH2CH2COOR, CH2CH(CH3)2, CH2C6H5, CH(CH3)CH2CH3 and CH3; R? is selected from the group consisting of CH2COOR, CH2CH2COOR, CH2CH(CH3)2, CH2C6H5, CH(CH3)CH2CH3 and CH3; R?? is a group selected from the group consisting of CH2COOR, CH2CH2COOR and H, wherein R is the same as defined above; n is a number between from 30 to 100; x is a number selected from the integers of 3, 4, 7, 12 and 16; y is a number between from 0.5 to 1.5; a equals to 1; and b and c equal to 0 or 1.

Abstract: Provided are a boron compound-layered double hydroxide (LDH) nanohybrid in which a boron compound for boron neutron capture therapy is intercalated in between layers of LDH, a method of preparing the boron compound-LDH nanohybrid, and a pharmaceutical composition including the boron compound-LDH nanohybrid, which can be used in boron neutron capture therapy.

Abstract: The present invention provides a novel fluorescent chemosensor including a naphthalene diimide-Zn(II) complex, which can efficiently recognize pyrophosphate (PPi) at pH 7.4. The fluorescent chemosensor exhibits a new kind of excimer fluorescence, which is selective for PPi in 100% aqueous solution. Further, since the naphthalene diimide-Zn(II) complex of the present invention does not couple with inorganic phosphate (Pi) or adenosine triphosphate (ATP) and has high selectivity for PPi, it can be usefully used to detect pyrophosphate (PPi), which serves to transfer signals and store energy in living organisms.

Abstract: Disclosed is an alanine racemase chiral binaphthol derivative having the ability to recognize amino alcohols selectively on the basis of chirality and transform amino acids from an L-form into a D-form. Methods for the optical resolution of amino acid or amino alcohol and for the optical transformation of D- and L-forms of amino acids using the binaphthol derivative are also provided.

Abstract: Provided are a boron compound-layered double hydroxide (LDH) nanohybrid in which a boron compound for boron neutron capture therapy is intercalated in between layers of LDH, a method of preparing the boron compound-LDH nanohybrid, and a pharmaceutical composition including the boron compound-LDH nanohybrid, which can be used in boron neutron capture therapy.

Abstract: 2-pyridyl-substituted imidazoles which are used advantageously in the treatment of diseases mediated by ALK 5 or ALK 4 receptor or both.

Abstract: Embodiments of the invention provide a device and a method for automatically testing embedded software, and more specifically for testing interfaces between layers of the embedded software. In one embodiment, the device includes: an emulator; a server including embedded software; an evaluation board configured to download the embedded software from the server and controlled by the emulator; and a host system configured to receive the embedded software from the server and automatically generate test cases for testing the embedded software using the emulator.

Abstract: Disclosed herein is a method of inducing the differentiation of leukemia cells derived from human bone marrow into megakaryocytes or thrombocytes, comprising the steps of: (a) culturing OP9 cells; (b) layering leukemia cells derived from human bone marrow over the OP9 cells; and (c) incubating the cells in the presence of a compound ((R)-NALPCE) represented by Chemical Formula 1.

Abstract: Provided is an apparatus and method for automatically extracting an interface of embedded software. The method defines an interface of embedded software as a test item for test of the interface of the embedded software, and generates an interface symbol corresponding to the defined test item. The location of the interface symbol is determined, and a test case is generated based on the interface symbol and its location in the software. Embodiments of the invention thus facilitate the testing of software at interfaces between layers in the software.

Abstract: The present invention relates to a micro- or nano-fluidic chip fabricated with a NOA. Said micro- or nano-fluidic chip comprises sequentially an inlet, a channel, and an outlet, wherein the channel has pillar in the region of the outlet to prevent beads from flowing out. The surface of channels in the micro- or nano-fluidic chip of the invention is hydrophilc, which generates spontaneous flow in the channels by a capillary force without any extra external pumping.

Abstract: Disclosed is a method of changing the seed productivity of a plant by controlling the level of AtSPF3 in the plant. More specifically, disclosed is a method of changing the seed productivity of a plant by controlling the intracellular level of a polypeptide having the amino acid sequence represented by SEQ ID NO: 1. The AtSPF3 gene has the effect of changing the seed productivity of a plant through an increase or decrease in the expression thereof in the plant. Accordingly, the AtSPF3 gene will be useful for increasing the production of plants and breeding plants.

Abstract: The present invention relates to an IP address lookup method and hardware architecture.

Abstract: Compounds of the formula: wherein R1, R2, R3, A1 and A2 are as defined herein, which are used advantageously in inhibiting the TGF-? and/or activin signaling pathway in mammals.